Title : First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients.

Pub. Date : 2011 Apr

PMID : 20705357






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 However, for patients who had received first-line docetaxel/gemcitabine, overall survival was 14.8 months with EGFR TKIs and 10.8 months with chemotherapy (P = 0.29). gemcitabine epidermal growth factor receptor Homo sapiens